Items Tagged ‘Psoriatic Arthritis’

FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis

October 26th, 2017

FDA Extends Simponi Approval to Psoriatic Arthritis and Ankylosing Spondylitis

By cancerconnect cancerconnect

The US Food and Drug Administration recently approved Simponi (golimumab) for the treatment of adult patients with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS), which is administered as a 30-minute infusion. Simponi was originally approved in 2013 for the treatment of moderate-to-severe active rheumatoid arthritis.  Simponi® is one of five marketed TNF inhibitors […]

View full entry

Tags: Ankylosing Spondylitis, Ankylosing Spondylitis (AS), AS, golimumab, News Tips and Features, PsA, Psoriatic Arthritis, Simponi


Cosentyx Highly Effective for Treatment of Scalp Psoriasis

September 25th, 2017

Cosentyx Highly Effective for Treatment of Scalp Psoriasis

By cancerconnect cancerconnect

Psoriasis is a chronic skin condition caused by an overactive immune system affecting 1-3% of people in the United States. Symptoms include flaking, inflammation, and thick, white, silvery, or red patches of the skin and scalp.  Psoriasis can also cause discoloration and pitting of finger and toenails as well as inflammation of the joints and […]

View full entry

Tags: Cosentyx, interleukin 17A, News Tips and Features, plaque psoriasis, Psoriatic Arthritis, secukinumab


Obesity- More Than a Weight Problem for Ankylosing Spondylitis (AS) and Other Rheumatic Conditions

July 31st, 2017

Obesity- More Than a Weight Problem for Ankylosing Spondylitis (AS) and Other Rheumatic Conditions

By cancerconnect cancerconnect

Obesity is known to have detrimental effects on the musculoskeletal system because of the added strain on joint structures.  Another detrimental effect may be the blunting of a therapeutic response to a therapy. It has previously been reported that decreasing weight in psoriatic arthritis results in an improved responses to treatment with tumor necrosis factor […]

View full entry

Tags: Ankylosing Spondylitis, antibody therapy, axial spondyloarthritis, axSpA, Obesity, Psoriatic Arthritis, rheumatoid arthritis, TNFi, tumor necrosis factor


Xeljanz Effective in Ulcerative Colitis

May 17th, 2017

Xeljanz Effective in Ulcerative Colitis

By cancerconnect cancerconnect

Xeljanz (tofacitinib) is currently approved by the U. S. Food and Drug Administration (FDA), for use in the treatment of rheumatoid arthritis.  Xeljanz is also being studied in numerous other inflammatory conditions including ankylosing spondylitis, psoriatic arthritis and ulcerative colitis (UC), a form of inflammatory bowel disease. UC is an inflammatory bowel disorder (IBD) as […]

View full entry

Tags: Ankylosing Spondylitis, inflammatory bowel disease., News Tips and Features, Psoriatic Arthritis, rheumatoid arthritis, ulcerative colitis, Xeljanz tofacitinib


How To Enjoy The Holidays Despite Chronic Pain

December 20th, 2016

How To Enjoy The Holidays Despite Chronic Pain

By cancerconnect cancerconnect

By Tom Macek, M.D. The holidays are a time when everyone is encouraged to be of good cheer. But this joyous time of year is a lot less merry for those suffering from chronic bad backs, migraines, arthritis and other pain-inducing ailments. “Any kind of pain can seriously affect your quality of life,” says Dr. […]

View full entry

Tags: Ankylosing Spondylitis, Axial Spondyloarthropathy (axSpA), back strain, News Tips and Features, osteoarthritis, Psoriatic Arthritis, rheumatoid arthritis, Spondylolysis/Spondylolisthesis


Cosentyx® Improves Pain and Function in Patients with Psoriatic Arthritis

September 22nd, 2016

Cosentyx® Improves Pain and Function in Patients with Psoriatic Arthritis

By cancerconnect cancerconnect

By David Borenstein MD, Executive Editor, theSpineCommunity.com In January of 2016, the Food and Drug Administration approved Cosentyx® (secukinumab) for the treatment of psoriatic arthritis (PsA) and ankylosing spondylitis. Psoriatic spondylitis, an inflammatory spine disease, is a component of PsA responsive to Cosentyx therapy. The availability of Cosentyx allows another option for PsA patients with spine […]

View full entry

Tags: News Tips and Features, PsA, Psoriatic Arthritis


FDA Arthritis Advisory Committee Recommends Approval of Adalimumab Biosimilar

August 23rd, 2016

FDA Arthritis Advisory Committee Recommends Approval of Adalimumab Biosimilar

By cancerconnect cancerconnect

The Food and Drug Administration’s Arthritis Advisory Committee recommended that Amgen biosimilar (ABP 501) to Humira (adalimumab) be approved for use in the United States. The panel unanimously voted, 26-0, that ABP 501 be recommended for use in the same indications as adalimumab: rheumatoid arthritis (RA), juvenile idiopathic, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, adult Crohn’s disease, […]

View full entry

Tags: Ankylosing Spondylitis, News Tips and Features, Psoriatic Arthritis, rheumatoid arthritis


Long-Term Safety of Humira® Reported in Analyses of over 15,000 Patients

August 9th, 2016

Long-Term Safety of Humira® Reported in Analyses of over 15,000 Patients

By cancerconnect cancerconnect

A review of the long-term outcomes and safety issues associated with the TNF inhibitor, Humira® (adalimumab) was recently published. Humira works by blocking the inflammatory effects of a protein called tumor necrosis factor alpha (TNF alpha) in rheumatoid arthritis (RA) and other conditions associated with inflammation. The body produces TNF when there is inflammation and […]

View full entry

Tags: Ankylosing Spondylitis, News Tips and Features, Psoriatic Arthritis, rheumatoid arthritis


What is EULAR and Why You Should Care

June 7th, 2016

What is EULAR and Why You Should Care

By cancerconnect cancerconnect

By David Borenstein MD, Executive Editor, theSpineCommunity.com What is EULAR? EULAR is an acronym for the European Union League Against Rheumatism. It is the second largest professional rheumatologic organization. The annual meeting for this organization is taking place next week in London, England, where more than a thousand presentations and abstracts will be presented about back […]

View full entry

Tags: Ankylosing Spondylitis, News Tips and Features, Osteoporosis, Psoriatic Arthritis, rhe


Strength Train at Home

April 29th, 2016

Strength Train at Home

By cancerconnect cancerconnect

Maintaining muscle strength through regular exercise as we age can help combat natural muscle loss, or sarcopenia. By Joan Pagano Sarco-What? Sarcopenia is the natural loss of muscle strength and function that occurs with aging. If you are over 40, you are already experiencing creeping muscle loss. Is it reversible? Yes—but only with an appropriate […]

View full entry

Tags: Ankylosing Spondylitis, back strain, Diffuse Idiopathic Skeletal Hyperostosis (DISH), Enteropathic Arthritis, Herniated Discs, News Tips and Features, osteoarthritis, Osteoporosis, Psoriatic Arthritis, Reactive Arthritis, rheumatoid arthritis, Scoliosis


CONDITIONS OF THE GI TRACT